Organ donors with malignant gliomas: An update

被引:28
作者
Collignon, FP
Holland, EC
Feng, S [1 ]
机构
[1] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Neurosurg, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA
关键词
CNS tumor; glioma; malignancy; organ donor; tumor transmission;
D O I
10.1046/j.1600-6143.2003.00289.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
The escalating shortage of organs motivates frequent reconsideration of concepts that guide the decision to accept or decline organs from donors with central nervous system (CNS) malignancy. Currently, a minority of patients who die annually of CNS malignancies are organ donors. Specifically, the organs of less than 0.5% of the 13 000 patients dying from glioma are procured and transplanted every year in the United States. This review seeks to clarify the risk of cancer transmission from transplantation of organs from donors with glioma. After considering historical precedence, we will systematically outline the clinical features of a potential organ donor with glioma that might reflect upon the risk of cancer transmission. We will then present recent knowledge regarding basic glioma biology that speaks to their metastatic potential and suggest rational strategies for the post- transplant management of recipients of organs from donors with glioma.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 30 条
[1]   CANCER STATISTICS, 1994 [J].
BORING, CC ;
SQUIRES, TS ;
TONG, T ;
MONTGOMERY, S .
CA-A CANCER JOURNAL FOR CLINICIANS, 1994, 44 (01) :7-26
[2]   Interferon-alpha and the cure of metastasis of a malignant meningioma in a kidney allograft recipient: A case report [J].
Bosmans, JL ;
Ysebaert, D ;
DeCock, AM ;
Hauben, E ;
Muylle, L ;
Schrijvers, D ;
VanMarck, E ;
Eyskens, E ;
DeBroe, ME .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :838-838
[3]   Risk of tumor transmission in transplantation from donors with primary brain tumors: An Australian and New Zealand Registry report [J].
Chui, AKK ;
Herbertt, K ;
Wang, LS ;
Kyd, G ;
Hodgeman, G ;
Verran, DJ ;
DeLeon, C ;
Sheil, AGR .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :1266-1267
[4]  
COLQUHOUN SD, 1994, TRANSPLANTATION, V57, P970
[5]   PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo [J].
Dai, C ;
Celestino, JC ;
Okada, Y ;
Louis, DN ;
Fuller, GN ;
Holland, EC .
GENES & DEVELOPMENT, 2001, 15 (15) :1913-1925
[6]  
Davies MA, 1998, CANCER RES, V58, P5285
[7]  
Davis F G, 1999, Neuro Oncol, V1, P205, DOI 10.1093/neuonc/1.3.205
[8]  
Fecteau AH, 1998, CLIN TRANSPLANT, V12, P348
[9]   Transmission of glioblastoma multiforme through liver transplantation [J].
Frank, S ;
Müller, J ;
Bonk, C ;
Haroske, G ;
Schackert, HK ;
Schackert, G .
LANCET, 1998, 352 (9121) :31-31
[10]   Proliferation of human malignant astrocytomas is dependent on Ras activation [J].
Guha, A ;
Feldkamp, MM ;
Lau, N ;
Boss, G ;
Pawson, A .
ONCOGENE, 1997, 15 (23) :2755-2765